Substantial Triglyceride Reduction With Plozasiran Substantial Triglyceride Reduction With Plozasiran

In patients with severe hypertriglyceridemia who are at risk for acute pancreatitis, the drug brought about triglyceride reductions of more than 50% in the phase 2 SHASTA-2 study.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Cardiology News Source Type: news